Press Release: Alcami Adds Solid-State Characterization Capabilities
Morrisville, North Carolina – September 22, 2022 – Alcami, a U.S.-based pharmaceutical contract...
Posts about
Analytical Development
Alcami Adds Additional Formulation Development Capabilities
Formulation Development Suite to Support Small and Large Molecule Programs
Morrisville, North...
Alcami Expands Biologics Footprint with Investment in Durham
$10 Million Investment Doubles Laboratory Footprint & Enhances Large Molecule and Cell & Gene...
Bioanalytical Testing Trends in 2022
An increasing number of clinical trial registrations, more R&D investment, growing demand for...
Alcami Announces the Acquisition of Masy BioServices
Acquisition to add 375,000 ft² of cGMP Biostorage and Pharma Support Services
Alcami to Provide Analytical Support Services for Novavax’ COVID-19 Vaccine Candidate
DURHAM, N.C. – November 16, 2021 – Alcami, a leading United States-based contract development and...
Outsourcing Trends in the Development of Biologics
The development of biologic drugs continues to increase at a rapid pace. Growing numbers of...
Fill-Finish Development Challenges & Solutions for CDMOs
Recently, contract development and manufacturing organizations (CDMOs) involved in the...
White Paper: Host Cell Impurities, Bioassays, Micro-Flow Imaging
As opposed to traditional drug production, the production of biological products (biologics)...
On-Demand Lab Open House
From standalone projects through full-service programs, our laboratories provide solutions to your...
White Paper: Leveraging Inductively Coupled Plasma Mass Spectrometry To Its Full Potential
Today’s technology has not only changed the way we receive information, but has continually adapted...
Full-Time Equivalent Programs: Outsourcing Analytical Testing
Alcami’s end-to-end analytical testing platform supports clients’ programs through every stage of a
Benefits of Establishing a Full-Time Equivalent (FTE) Program
A Full-Time Equivalent (FTE) agreement is a comprehensive analytical service that grants...
Alcami Helps Secure FDA Approval for MDGH
Durham, NC (USA) – October 25, 2018 – Alcami Corporation, a leading provider of fully-integrated...
ON-DEMAND WEBINAR: Extractables & Leachables
Requirements from regulatory agencies have become increasingly rigorous with regards to the...
The Role of FTE (FULL TIME EQUIVALENT) Programs
An FTE agreement is considered a comprehensive analytical service that allows pharmaceutical and...
Alcami’s Extended Workbench Supports Commercial Supply of Flexion Therapeutics’s ZILRETTA® (triamcinolone acetonide extended-release injectable suspension)
Durham, NC (USA) – June 13, 2018 – Alcami Corporation, a leading provider of fully-integrated...
Abuse-Deterrent Studies – An Interview with Angela Moore
As one of the key contributors to current abuse-deterrent studies being performed in the Alcami...